LSBio
Polyclonal Rabbit anti-Human ARHGAP17 / NADRIN Antibody (aa331-380, WB)

Western blot analysis of lysates from LOVO cells, using RHG17 Antibody. The lane on the right is blocked with the synthesized peptide.

Polyclonal Rabbit anti-Human ARHGAP17 / NADRIN Antibody (aa331-380, WB)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all Human ARHGAP17 / NADRIN antibodies →
$341.00each
Catalog Number: LS-C120326-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
NADRIN antibody LS-C120326 is an unconjugated rabbit polyclonal antibody to NADRIN (ARHGAP17) (aa331-380) from human. It is reactive with human, mouse and rat. Validated for Peptide-ELISA and WB. Cited in 1 publication.
Application
ELISA, IHC, WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
ARHGAP17 | MST110 | MSTP038 | MSTP066 | MSTP110 | NADRIN | RICH1B | PP367 | RICH1 | MST066 | PP4534 | RICH-1 | WBP15
Recommended Dilution: WB
1:500 - 1:1000
UniProt Number
Q68EM7
SwissProt
Q68EM7

Target

Target
Human ARHGAP17 / NADRIN
Antigen Species
Human
Epitope
RHG17 Antibody detects endogenous levels of total RHG17 protein.
Gene Name
ARHGAP17

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Synthetic peptide from human RHG17. (AA Range: 331-380)
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS (without Mg2+, Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide, 50% Glycerol
Concentration
1 mg/mL
Volume
50 Microliter
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C for up to 1 year.
Recommended Storage Buffer
PBS|150 mM NaCl
Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. Kiso M, Tanaka S, Saji S, Toi M, Sato F. International journal of cancer. Journal international du cancer. 2018 December;143:2905-2918. PubMed: 29971782 PMC: PMC6282968

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.